Display options
Share it on

Iran J Pathol. 2015;10(1):54-60.

Microbial Etiology and Antimicrobial Susceptibility of Bactria Implicated in Urinary Tract Infection in Tehran, Iran.

Iranian journal of pathology

Zohreh Nozarian, Alireza Abdollahi

Affiliations

  1. Dept. of Pathology, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran.
  2. Dept. of Pathology, Imam Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran ; Thrombosis Hemostasis Research Center, Imam Hospitals Complex, Tehran University of Medical Sciences, Tehran, Iran.

PMID: 26516326 PMCID: PMC4539787

Abstract

BACKGROUND AND OBJECTIVES: Urinary tract infections (UTI) are one of the most common infectious diseases with different microbial agent and antimicrobial resistant pattern in hospitalized patients and outpatients. In order to assess the adequacy of therapy, knowledge of prevalence and resistance pattern of the bacteria is necessary. The main aim of this study was to evaluate the prevalence and the antimicrobial resistance pattern of main bacterial responsible for UTI in order to establish an appropriate empirical therapy.

METHODS: All urine samples were referred to Imam Hospital Laboratory, Tehran, Iran during 2011-2012, urine culture isolated and bacteria were identified and the profile of antibiotic susceptibility was characterized.

RESULT: From 1851 urine cultures, UTI was more frequent in woman (68%) E. coli was as usual the most common pathogen implicated in UTI. Most susceptibility was to imipenem (98.9%). nitroforantoin (96%) and amikacin (94.1%) and increased resistance to penicillin (66.6%), nalidixic acid (62.1%) ampicilin (60.1%) and cotrimoxazole 54.3%.

DISCUSSION: The most common isolated pathogen was E. coli . According to antibiogram susceptibility, the recommended antimicrobial drugs are nitroforantoin and imipenem. nalidixic acid and cotrimoxazole are not recommended because drug resistance is high.

Keywords: Antibiogram; Iran; Urinary Tract Infection

References

  1. Clin Microbiol Infect. 2001 Oct;7(10):543-7 - PubMed
  2. J Ayub Med Coll Abbottabad. 2007 Jan-Mar;19(1):39-41 - PubMed
  3. Med Sci Monit. 2007 Jun;13(6):BR136-44 - PubMed
  4. Rev Soc Bras Med Trop. 2007 Nov-Dec;40(6):643-7 - PubMed
  5. Clin Ther. 2007 Oct;29(10):2215-21 - PubMed
  6. Indian J Community Med. 2008 Apr;33(2):89-92 - PubMed
  7. BMC Infect Dis. 2013 Jan 18;13:19 - PubMed
  8. J Hosp Infect. 2003 Mar;53(3):207-10 - PubMed
  9. Int J Antimicrob Agents. 2005 Nov;26(5):380-8 - PubMed
  10. Mem Inst Oswaldo Cruz. 2006 Nov;101(7):741-8 - PubMed
  11. Int J Antimicrob Agents. 2001 Aug;18(2):189-92 - PubMed
  12. Ann Clin Microbiol Antimicrob. 2007 Mar 23;6:4 - PubMed
  13. J Antimicrob Chemother. 2008 Aug;62(2):364-8 - PubMed
  14. J Antimicrob Chemother. 2007 Feb;59(2):309-12 - PubMed
  15. West Indian Med J. 2006 Mar;55(2):95-9 - PubMed
  16. Malays Fam Physician. 2007 Aug 31;2(2):64-9 - PubMed

Publication Types